The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of osimertinib plus bevacizumab as first-line treatment in EGFR-mutated NSCLC with brain metastasis instructed by dynamic monitoring circulating tumor DNA of paired cerebrospinal fluid and plasma.
 
Fang Wei
No Relationships to Disclose
 
Juan An
No Relationships to Disclose
 
Yichun Hua
No Relationships to Disclose
 
Kuanyu Wang
No Relationships to Disclose
 
Xiaosheng Ding
No Relationships to Disclose
 
Lili Zhou
No Relationships to Disclose
 
Xixi Zheng
No Relationships to Disclose
 
Shibin Sun
No Relationships to Disclose
 
Xiaoyan Li
No Relationships to Disclose